Patient Guide: Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 138 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07106762
Status: 🟢 Enrolling Now
Condition: Urothelial Cancer
Phase: PHASE2, PHASE3

Where You Can Participate

This study is available at 138 locations across the country.

Top locations include:
  • • Gilbert, Arizona
  • • Fullerton, California
  • • Sacramento, California
  • • And 135 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy - Join Clinical Trial NCTNCT07106762

How to Join This Clinical Trial - NCTNCT07106762

Learn how to participate in this PHASE2, PHASE3 trial studying an investigational therapy for Urothelial Cancer. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Urothelial Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Urothelial Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2, PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07106762 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 138 locations. Find a study site near you:

Clinical Research Site

Gilbert, Arizona 85234 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Fullerton, California 92835 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Sacramento, California 95816 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Sacramento, California 95817 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Dillon, Colorado 80435 - United States

Status: WITHDRAWN

Clinical Research Site

Edwards, Colorado 81632 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Washington D.C., District of Columbia 20016 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Miami, Florida 33176 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Lexington, Kentucky 40536 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Baltimore, Maryland 21287 - United States

Status: NOT_YET_RECRUITING

And 128 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2, PHASE3 clinical trial for Urothelial Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships